Skip to main content
Caplight Logo









Relavo

Relavo

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://relavomedical.com

Last Round

Seed

May 1, 2024

Total Funding Raised

$2.54M

Company Overview

Relavo operates in Healthcare & Life Sciences and is based in Baltimore, Maryland. Its latest recorded funding round was a Seed round in May 2024.

Relavo is a medical device company developing the PeritoneX, a device that disinfects dialysis tubes to reduce the risk of infection for patients undergoing at-home peritoneal dialysis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Telemedicine

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Relavo Comparables

Compare Relavo with similar companies based on industry and business-model similarity.

Relavo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PuraCath Medical
83%
Peripal AG
80%
PeriShield
70%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Relavo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 1, 2024
GrantApr 26, 2022
Pre SeedAug 26, 2020
GrantAug 3, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Relavo Investors

Notable investors and investment history

Relavo investors
InvestorRounds
Citrine AngelsSeed
FastForward UPre Seed
New York VenturesSeed
San Diego Angel ConferenceSeed
National Kidney FoundationSeed
National Science FoundationGrant

Relavo Filings

Explore SEC and related filing metadata, where available.

Relavo filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Relavo's valuation, stock price, and market status.

Is Relavo a public or private company?

Relavo is a private company.

What is the current stock price of Relavo?

Relavo is a private company, so its shares have no public market price. Caplight tracks Relavo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Relavo worth (valuation)?

Valuation information for Relavo is not publicly available.

Can I buy Relavo stock?

Relavo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Relavo's last funding round?

Relavo's most recent funding round was Seed on May 1, 2024.

Who are the main investors in Relavo?

Key investors in Relavo include Citrine Angels, FastForward U, New York Ventures, San Diego Angel Conference, National Kidney Foundation.

Will Relavo IPO soon?

No public IPO plans have been announced for Relavo.

How can I track Relavo secondary market activity?

Caplight tracks bids, offers, and trades in Relavo's shares on secondary markets.

Firmographic Details

HeadquartersBaltimore, Maryland
Year Founded2018
Last FundingMay 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?